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Ⅰ．Introduction
 Granulosa cell tumors （GCTs） are sex cord-
stromal cell tumors that arise from the ovaries and 
produce different types of hormones, including 
estrogens, androgens, and inhibins that cause specific 
and pathognomonic symptoms. In menopausal women, 
recurrent abnormal uterine bleeding is the most common 
sign of estrogen-producing GCTs［1］. Persistent 
amenorrhea, although rare, is another sign of GCTs and 
is caused by inhibins［2］. Virilization （hirsutism and 
acne） can be caused by androgens released from GCTs
［3］.
 Women with GCTs exhibit any of these manifestations 
of tumor-producing hormones［4］. However, it is rare for 
GCTs to produce metachronous multiple manifestations. 
We report the case of a 50-year-old woman with GCT 
whose manifestations changed over a period of 9 years: 
persistent amenorrhea for 9 years, which was thought 
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Abstract
The signs of granulosa cell tumors （GCTs） arising from the ovary depend on the types of hormones 
produced by the tumor. Estrogens cause continuous uterine bleeding, whereas inhibins are responsible 
for amenorrhea. We describe an unusual case of GCT in which the tumor-related manifestations changed 
over 9 years, from initial secondary amenorrhea to continuous uterine bleeding. Magnetic resonance 
imaging revealed a suspected ovarian tumor, and bilateral adnexectomy was performed. The preoperative 
serum hormone levels （luteinizing hormone, 0.5 mIU/mL; follicle-stimulating hormone, ＜0.05 mIU/mL; 
estradiol, 279 pg/mL） returned to the normal menopausal range after tumor resection （11.43 mIU/
mL, 23.80 mIU/mL, and ＜10 pg/mL, respectively）. The preoperative serum inhibin B levels were high, 
and the tumor tissue was diffusely immunostained with inhibin α. The woman had never experienced 
estrogen-deficiency symptoms. Therefore, we believe that the tumor produced inhibins initially, which 
led to hypogonadotropic amenorrhea that manifested as apparent early menopause, and estrogens 
subsequently, which caused continuous uterine bleeding over the years.
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to be early menopause, followed by continuous uterine 
bleeding for 1 year.
Ⅱ．Case
 A 50-year-old nulliparous woman who was obese 
（height, 154 cm; weight, 81 kg; body mass index, 
34） presented with lower abdominal pain and a 1-year 
history of continuous uterine bleeding. Menarche had 
occurred at 13 years of age, and her menstrual cycles 
were regular until the age of 40, when amenorrhea 
developed. She reported never having experienced 
menopause-related symptoms, such as hot flashes, 
moodiness, or episodic sweating. A tender lower 
abdominal tumor （22 × 18 × 8 cm） was found 
on magnetic resonance imaging （MRI）. The height 
of uterine fundus was 10.8 cm at the long axis, and 
the endometrium was 8 mm thick （normal for the 
proliferative phases）. Trace amounts of dark red blood 
were present in her vagina; however,  characteristic 
postmenopausal atrophic changes were not apparent in 
her vulva or vagina. Results of cervical and endometrial 
cytology tests were negative for malignancy.
 An endometrial biopsy revealed endometrial 
tissue in mixed proliferative and secretory phases, 
which indicated a continuous estrogenic effect on the 
endometrium. MRI revealed a right ovarian multilocular, 
cystic tumor comprising a solid part with low- and high-
intensity areas on T2-weighted images （Fig. 1）. A few 
small cysts were also noted in the left ovary. The MRI 
findings were consistent with the diagnosis of GCT. 
The left ovary was 2.5 × 2.0 × 1.8 cm in size. Blood 
examination revealed normocytic anemia （red blood 
cell count, 25.3 × 106/mL; hemoglobin, 6.7 g/dL; 
hematocrit, 21.3%; mean cell volume of red blood cells, 
84.9 fL）. Serum hormone levels－low gonadotropins 
and high estradiol－were not characteristic of 
menopause （Table 1）. Inhibins are heterodimers 
consisting of α, βA, and βB subunits with a disulfide 
bond. We identified elevated levels of serum inhibin 
B （754.1 pg/mL; normal range, 10-200 pg/mL） by 
using the RayBio® Human/Mouse/Rat Inhibin B （Beta 
B subunit） Enzyme Immunoassay Kit （RayBiotech, 
Norcross, GA, USA）［5］.
 We performed total hysterectomy, bilateral 
adnexectomy, and partial omentectomy. The tumor 
capsule was found to be partly ruptured. Results of 
peritoneal cytologic tests were negative for malignancy. 
Pathological study of the resected tumor demonstrated 
the presence of an adult-type GCT （stage pT1c2（IC2）, 
according to the International Federation of Gynecology 
and Obstetrics ［FIGO］ classification of ovarian cancer
Table 1　Serum gonadotropin and sex steroid levels before and after surgery.
One day before surgery
After surgery
Day 1 Day 7 Day 30
LH （mIU/mL） 0.05 0.27 1.01 11.43
FSH （mIU/mL） ＜0.05 ＜0.05 1.16 23.8
Estradiol （pg/mL） 279 10 ＜10 ＜10
Testosterone （ng/mL） 0.53 0.1
Progesterone （ng/mL） 0.2 ＜0.1
　　　   LH, luteinizing hormone; FSH, follicle stimulating hormone.
Fig. 1　Magnetic resonance imaging findings of the tumor
　（a） Sagittal T1-weighted image. Maximum tumor 
diameter was 22 cm. Bleeding area showed high intensity. 
（b） Sagittal T2-weighted image. The multilocular cystic 
mass included low- and high-intensity areas. A solid part 
was recognized in the cystic tumor.
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［6］） with Call-Exner bodies and coffee bean-shaped 
nuclei. Immunostained tumor cells showed diffuse 
expression of inhibin α （Fig. 2）. With genomic DNA 
extracted from frozen tumor tissue, we performed direct 
sequencing of the FOXL2  gene. The tumor tissues were 
heterozygous for a missense mutation at c.402C＞G 
（p.C134W）, a frequent observation in adult-type GCT
［7］.
 After the surgery, serum gonadotropin levels 
increased to the postmenopausal range, and the serum 
estrogen levels became undetectable （Table 1）. The 
serum inhibin B levels were increased slightly on day 
1 after surgery （903.5 pg/mL）, and were decreased 
on day 7 （647.4 pg/mL）. We administered adjuvant 
chemotherapy in six cycles of paclitaxel （175 mg/m2） 
and carboplatin （area under the curve, 6） every 3 week, 
in accordance with the standard regimen for women 
with ovarian cancer. No recurrence of the tumor has 
been observed for five years after the surgery.
Ⅲ．Discussion
 To our knowledge, no case of GCT like ours－
manifesting with amenorrhea for 9 years, followed 
by continuous abnormal uterine bleeding－has been 
reported. We believe that both the persistent amenorrhea, 
which was assumed to be early menopause, and 
continuous uterine bleeding were associated with a 
transition in the expression of the major tumor-induced 
hormones, from inhibin to estrogen. The prolonged 
amenorrhea may have resulted from hypogonadotropic 
anovulation, and the continuous uterine bleeding may 
have represented endometrial breakthrough caused by 
hyperestrogenemia.
 Secondary amenorrhea is one of the signs of an 
inhibin-producing GCT. Excess inhibins secreted from 
the GCT may suppress pituitary secretion of follicle-
stimulating hormone （FSH）, which in turn suppresses 
ovulation and results in secondary amenorrhea. Such 
hypogonadotropic amenorrhea in a woman 40 years of 
older is assumed to represent menopause. Our patient 
exhibited extremely low levels of serum FSH and 
high levels of serum inhibin B while uterine bleeding 
continued; after resection of GCT, the FSH levels 
returned to menopausal levels. Therefore, we concluded 
that her secondary amenorrhea, which is an apparent 
early menopause, was caused by hypogonadotropic 
hypogonadism.
 In a previous report of GCT, a woman presented 
with menopause at 44 years of age［8］; at the age of 48, 
this patient complained of atypical vaginal bleeding, 
and laboratory testing revealed undetectable FSH 
levels in association with a high estradiol level, as in 
our patient. In another reported case of GCT, a woman 
presented with menopause at the age of 43, followed by 
postmenopausal mild hirsutism and hyperandrogenemia
［9］. Resumption of menstruation in women with GCTs 
who presented with secondary amenorrhea has also been 
reported.
 Although the mechanisms of menstrual cessation 
a b c 
Fig. 2　Pathological findings of the ovarian tumor
　（a） Macroscopic findings of the tumor. The surface and lumen of the cyst were smooth. A necrotic lesion with massive 
bleeding was observed in the solid portion. （b） Microscopic findings of the tumor at low magnification （×40）. Call-Exner 
bodies （arrows） was observed in the lumen of the cyst. （c） Immunohistochemistry of the tumor for inhibin α. We observed 
diffuse inhibin α expression around the lumen of the gland portion.
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inhibin B might have been impaired in our patient. In 
addition, serum levels of inhibins remained high during 
the continuous uterine bleeding, and this may have 
caused the secondary amenorrhea to last for 9 years.
 In conclusion, women with GCTs present with 
specific signs associated with the hormones produced 
by the tumors. Changes in the main sign may result 
from a change in the dominant hormone produced by 
a GCT. Both serum hormone levels and the associated 
symptoms are helpful for the identification of GCTs. 
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